Join the Dalhousie Student Union and Student Health and Wellness for the next Dalhousie Mental Health Forum this Wednesday November 23 from 4:-5:30 pm.
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.
Today@Dal is a service of Dalhousie Communications, Marketing and Creative Services. It is linked with both Dal News and the university Events Calendar.
To subscribe to the daily newsletter, send an email to listserv@lists.dal.ca containing the message: sub dal-news firstname lastname. Or subscribe from our website.
To unsubscribe, email listserv@lists.dal.ca containing the message: unsub dal-news. If you are forwarding to another email service, please include your NetID in the body copy, or else the automated subscription system will not work properly.